This book uses an economic approach to analyze the socioeconomic causes and consequences of mental health disorders in China, with a special focus on mental depression. Based on a nationally representative dataset, we first investigate the prevalence and distribution of depression and depressive...

The EU approved the first biosimilar drug in 2006. By 2017, the EU had authorized the highest number of biosimilars worldwide, acquiring considerable experience in their use and safety. In May 2019, the European Medicines Agency (EMA) search engine showed 54 authorized biosimilars. Biosimilars...